Versant Venture Management, LLC - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 137 filers reported holding FLEXION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,100,000
-25.9%
1,000,0000.0%2.53%
-7.4%
Q2 2021$8,230,000
-29.8%
1,000,000
-23.7%
2.73%
+19.3%
Q1 2021$11,726,000
-73.6%
1,310,169
-65.9%
2.28%
-50.4%
Q4 2020$44,343,000
+10.9%
3,842,5780.0%4.60%
-37.1%
Q3 2020$40,001,0003,842,5787.32%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Clearline Capital LP 391,076$7,317,0004.33%
Rubric Capital Management LP 2,125,000$39,759,0004.20%
Gagnon Advisors, LLC 225,062$4,211,0002.52%
GAGNON SECURITIES LLC 450,655$8,432,0001.94%
MILLER VALUE PARTNERS, LLC 2,881,200$53,907,0001.74%
PECONIC PARTNERS LLC 222,965$4,172,0001.05%
ARDSLEY ADVISORY PARTNERS LP 415,000$7,765,0001.05%
Rhenman & Partners Asset Management AB 532,812$9,969,0001.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 574,483$10,749,0000.75%
Kerrisdale Advisers, LLC 37,145$695,0000.68%
View complete list of FLEXION THERAPEUTICS INC shareholders